5 Best Genomics Stocks To Buy Now

Page 5 of 5

1. Natera, Inc. (NASDAQ:NTRA)

Number of Hedge Fund Investors In Q3 2023: 49

Natera, Inc. (NASDAQ:NTRA) is a diagnostics company that enables people to discover genetic abnormalities. Its shares are also rated Strong Buy on average and analysts have set an average share price target of $71.87.

49 out of the 910 hedge funds profiled by Insider Monkey had bought Natera, Inc. (NASDAQ:NTRA)’s shares during Q3 2023. Robert Pohly’s Samlyn Capital was the largest hedge fund shareholder as it owned $194 million worth of shares.

Follow Natera Inc. (NASDAQ:NTRA)

Disclosure: None. You can also take a look at 12 Most Promising Stocks to Buy According to Hedge Funds and Billionaire Louis Bacon’s 10 Stock Picks with Huge Upside Potential.

Follow Insider Monkey on Twitter

Page 5 of 5